Befejeződött1. fázis
A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin
A legfontosabb adatok
- Ki végzi
- Cinclus Pharma Holding AB
- Hol
- Svédország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Fázis
- 1. fázis
- Résztvevők
- 12 fő vett részt
- Kezdés
- 2025. nov. 11.
- Befejezés
- 2025. dec. 22.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Drug Drug Interaction
- A regiszteradat frissítve
- 2026. február 27.
Ki vehet részt
- Életkor
- 18 év – 64 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Willing and able to give written informed consent for participation in the trial
- Healthy male or female participant aged 18 to 64 years, inclusive
- Body mass index (BMI) ≥ 18.5 and ≤ 30.0 kg/m2 at the time of the screening visit
- Medically healthy participant without abnormal clinically significant medical history, physical findings, vital signs, ECG and laboratory values at the time of the screening visit, as judged by the Investigator
- Prospective participants, as well as their partners, must agree to the contraception requirements described in exclusion criteria 1 and 2
Ki nem vehet részt
- Female participants of childbearing potential (defined as all participants physiologically capable of becoming pregnant) unless they agree to use one of the following highly effective methods of contraception (failure rate of <1%) from 2 weeks prior to the first dose until the end-of-trial visit:; Sterilization of a male partner, defined as vasectomy, at least six months prior to screening; Intra-uterine device (non-hormonal or copper IUD); Double-barrier methods of contraception, i.e., condoms in combination with occlusive cap with contraceptive gel
- Male participants with a partner of childbearing potential, unless they agree to use one of the following methods of contraception from two weeks prior to the first dose until the end-of-trial visit:; Vasectomy at least six months prior to screening; Condoms. Female partners of childbearing potential must then agree to concurrently use a highly effective method of contraception
- Positive result for H.pylori antibodies at the time of the screening visit
- History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or influence the results or the participant's ability to participate in the trial
- Any clinically significant illness, medical/surgical procedure or trauma within four weeks of the first administration of IMP
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is an open, single arm, single-center Phase I trial designed to evaluate the effect of seven days repeated oral doses of linaprazan glurate on the pharmacokinetics (PK) of repeated doses of amoxicillin in healthy male and female participants
A vizsgálat csoportja
- Linaprazan glurateA vizsgált kezelés
Oral administration for seven (7) days.
Kezelés: Drug Drug Interaction
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- An Open, Single Arm, Single-center, Phase 1 Trial Investigating the Effect of 7-days-repeated Administration of Linaprazan Glurate on the Pharmacokinetics of Repeated Doses of Amoxicillin in Healthy Participants
- A regiszteradat frissítve
- 2026. február 27.